Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
IVDs
|
Imaging & IT
|
Cardiovascular
|
Orthopaedics
|
Surgical & Wound care
|
Cellular & Genetic
|
Neurological
|
Other
|
clinica
Market Sector
Immediate improvements sought in EU-wide surveillance of medical devices post-PIP
03 February 2012
The European Commission is looking at "immediate measures" to improve the surveillance of medical devices within the existing legal framework in light of the sub-standard PIP breast implants affair. The commission will launch a discussion with all ...
 
UK genomics report calls for strategic innovation
27 January 2012
The UK's Human Genomics Strategy Group (HGSG), established as part of the UK government's response to the 2009 House of Lords Inquiry into genomic medicine, has made a series of recommendations that it believes will enable the healthcare system in ...
Quintiles invests in cancer biomarker start-up
26 January 2012
Quintiles has invested £3m ($4.7m) in a new company formed in partnership with the University of Oxford and two of its professors, which will provide oncology consulting services and new cancer biomarkers to clients for personalised medicine ...
 
Canon enters medical informatics with Delft acquisition
03 February 2012
Canon Europe, part of the Japanese imaging and camera specialist Canon , has bought Dutch firm Delft Diagnostic Imaging, expanding its X-ray capabilities and giving it a foothold in the medical informatics market. Financial terms of the deal were ...
European Commission officially sets up eHealth Network
30 December 2011
The European Commission has published an implementing decision which lays out the rules for the establishment, management and functioning of the eHealth Network. The decision was dated 22 December. This network, comprising national responsible ...
 
J&J suffers knock-back in drug-eluting stent wars
26 January 2012
Johnson & Johnson was dealt a blow recently in its courtroom wrangling with rival heart stent makers Abbott, Boston Scientific and Medtronic over patents relating to the devices' drug coating. Last week, a US district court judge in New Jersey ...
Terumo steps into left atrial appendage closure market with TigerPaw II
24 January 2012
Terumo Cardiovascular Systems has entered a new segment of the cardiac surgery market with an exclusive US distribution deal for TigerPaw II, a left atrial appendage (LAA) closure device. TigerPaw II, developed by privately-held Livermore, ...
 
PIP breast implants sold in 71 countries, not 66, according to French report
02 February 2012
The French government has published a comprehensive report on the history, current situation and implications of the crisis involving fraudulent silicone breast implants made by the now-defunct Poly Implant Protheses (PIP). Among the most ...
BioMimetic's star continues to fall as it cuts 25% workforce
30 January 2012
BioMimetic Therapeutics has slashed 25% of its workforce, or around 20 employees, as it seeks to curb expenditure after approval of its Augment bone graft was delayed. Earlier this month the US FDA rejected the firm's premarket approval (PMA) ...
 
Medtech veteran Matricaria to oversee reshuffle at Kinetic; mulls sale of therapeutic systems unit
01 February 2012
Ronald Matricaria, a veteran of the medical device industry, has been elected chairman of the board of directors at wound care company Kinetic Concepts and LifeCell, Kinetic's sister wound care company owned by the same private equity firm Apax ...
Quarterly results round-up: Intuitive and Zoll on the up, Varian's bottom line suffers
26 January 2012
Continued uptake of its robotic surgery technology enabled Intuitive Surgical to beat analysts' predictions for its top and bottom lines during its fourth fiscal quarter. The developer of the da Vinci surgical robots reported a 28% year-on-year ...
 
US FDA warns public of fraudulent stem cell schemes
10 January 2012
US regulators have warned consumers about fraudsters peddling potentially dangerous and ineffective stem cell treatments. They noted that only one stem cell product is approved by the US FDA – Hemacord, a haematopoietic progenitor cell product ...
Sanofi licenses regenerative osteoarthritis treatment from Scil
21 December 2011
Sanofi has exclusively licensed Scil Technology's preclinical stage programme for a regenerative treatment of osteoarthritis and cartilage disorders. Under the agreement, privately-held Scil of Germany will receive an upfront payment and potential ...
 
FDA slaps Class I stamp on CareFusion recall of brain mapping system
24 January 2012
The US FDA has given CareFusion's recall of its Nicolet cortical stimulator system the most serious Class I designation. The cortical stimulator is used to identify brain structures during brain mapping procedures, carried out in the operating room ...
Bracco and Cyberonics back on track after FDA gives thumbs up to recalled products
09 January 2012
Vagal nerve stimulation specialist Cyberonics and contrast agent developer Bracco Diagnostics have had a good start to 2012, after the US FDA gave both companies the go-ahead to start reselling products that were recalled last year. The agency has ...
 
Quarterly results round-up: Intuitive and Zoll on the up, Varian's bottom line suffers
26 January 2012
Continued uptake of its robotic surgery technology enabled Intuitive Surgical to beat analysts' predictions for its top and bottom lines during its fourth fiscal quarter. The developer of the da Vinci surgical robots reported a 28% year-on-year ...
Brazil sets new standard in PIP follow-up; major replacement network ready
26 January 2012
Brazil’s health ministry has published comprehensive technical guidance on the follow-up of PIP and Rofil-rebranded PIP silicone breast implants, together with a list of almost 400 clinics that have been designated to undertake the replacement ...
 
The growing role of diagnostics-based models in combating antimicrobial resistance
30 January 2012
Ashley Yeo

Recent scientific and regulatory advances have pointed to the growing role of molecular diagnostics and personalised medicine in many areas including control of antimicrobial resistance. Ashley Yeo speaks to medical device industry consultant Trevor ...

 
Softening CRM sector in need of more pace and rhythm
03 February 2012
Ashley Yeo

Cardiac rhythm management remains a $2bn business at Boston Scientific , but a 15% slide (in both reported and constant currencies) in sales in the final quarter of 2011, reported yesterday, meant that the group’s second-largest business unit ...

 
Softening CRM sector in need of more pace and rhythm
03 February 2012
Cardiac rhythm management remains a $2bn business at Boston Scientific , but a 15% slide (in both reported and constant currencies) in sales in the final quarter of 2011, reported yesterday, meant that the group’s second-largest business unit ...
 Quarterly results round-up: Abbott staying conservatively op...   Boston launches two new defib families in Europe; offers US ...
Refurbishment and reprocessing - threat or opportunity for medical device manufacturers?
31 January 2012
Medical device refurbishment – restoring devices to their original specifications – has gained in importance as healthcare budgets have come under pressure. While some countries actively ban imports of such devices, attitudes generally towards the ...
The growing role of diagnostics-based models in combating antimicrobial resistance
30 January 2012
Recent scientific and regulatory advances have pointed to the growing role of molecular diagnostics and personalised medicine in many areas including control of antimicrobial resistance. Ashley Yeo speaks to medical device industry consultant Trevor ...

Advanced Therapies: is the EU regulatory approach putting a brake on market development?
19 January 2012
Amanda Maxwell

There is no doubt that the European Medicines Agency's Committee for Advanced Therapies (CAT) has put considerable effort into developing a significant number of guidelines to explain how it operates in the complex field of advanced therapy ...

 
Clinica 100
28 October 2011

This year's Clinica 100: Analysis of the Medtech Industry is now out with the December issue. This special 24-page section features: - Clinica League Tables - Top 100 medtech companies and Top 20 Sector Leaders - Interviews offering insight into ...

 
EVENTS
The 14th MedTech Investing Europe conference
19 March 2012
Montreux Convention and Music Centre, Switzerland
HTAi 2012
23 June 2012
Bilbao, Spain
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm